Publications
Specialty
Search
EP Lab Digest
08/26/2024
New analyses, including presentations on CAMZYOS® (mavacamten), ELIQUIS® (apixaban) and milvexian, further solidify the company's strength and expertise as a leader in cardiovascular diseases
Oncology
08/26/2024
According to a phase 2 trial, ruxolitinib therapy was associated with improvement in patient-reported outcomes, low non-relapse mortality, and high failure-free survival among patients with refractory sclerotic chronic GVHD.
Gastroenterology
08/26/2024
Aspirin use was associated with a greater absolute reduction in risk of colorectal cancer among people with unhealthy lifestyle factors.
Podiatry Today
08/25/2024
The authors stress the life-changing nature of this condition, with impact from significant arthritic changes, recurring flares, pain, and risk for ulceration.
EMSWorld
08/24/2024
As we in EMS know far too well, our patients never seemingly get hurt anywhere that’s easy to access. What would you have done for this kid?
Journal of Clinical Pathways
08/23/2024
Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase inhibitors (BTKis) approved for treatment of chronic lymphocytic leukemia (CLL). In this study, researchers used data from package inserts, clinical trials, and real-world evidence to evaluate the clinical benefits and commonly reported adverse events (AEs) to assess associated treatment-related and AE-related costs of BTKis.
Journal of Clinical Pathways
08/23/2024
Systemic therapies for metastatic colorectal cancer (mCRC) have distinct safety and tolerability profiles. Adverse events (AEs) may occur and compromise the course of treatment, increase health care utilization and costs, and worsen patients’ quality of life (QoL). A recent study compared the management costs of grade ≥ 3 AEs associated with fruquintinib, trifluridine/tipiracil (T/T), regorafenib, and T/T+bevacizumab (T/T+bev) for the treatment of mCRC previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy (standard therapies hereafter) and biologics in the US.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
08/23/2024
During Phase 2, the Company and Corewell Health will work together to develop the capabilities to perform simulated cardiovascular interventional procedures with LIBERTY across two sites within the Corewell Health system which are 5 miles apart. The project is led by Ryan Madder, MD, Section Chief of Interventional Cardiology and Director of the Cardiac Cath Lab at Corewell Health in West Michigan.
Journal of Clinical Pathways
08/23/2024
Drug waste poses a significant challenge in the field of health care, resulting in increased costs and environmental concerns. Using administrative claims data for Medicare patients from 15 practices in The US Oncology Network, researchers assessed the amount of drug waste and associated cost implications for bortezomib and carfilzomib.
Foot and Ankle Surgery Institute
08/23/2024
Dr. William Long presents a challenging case of a 72-year-old male with a decubitus diabetic foot ulcer.
Journal of Clinical Pathways
08/23/2024
Conducting a thorough and systemic evaluation of practice readiness for value-based care (VBC) programs empowers practices to make informed decisions about VBC model participation. VBC programs like the Enhancing Oncology Model (EOM) offers the opportunity for prospective participants to understand program requirements, risk/reward, and processes that will impact success. Learn more about the results of an assessment involving oncology practices that engaged in this model.
Journal of Clinical Pathways
08/23/2024
To fully understand and rectify impediments to optimal patient outcomes and experiences for patients with cancer, researchers reviewed health-related social needs (HRSN) to fully understand how to provide support to affected patients. Researchers highlight the complex nature of distress to help health care professionals, caregivers, and support systems coordinate social support services for patients with cancer.
Journal of Clinical Pathways
08/23/2024
Manual electronic health records (EHR) can help bridge the gap between patients with cancer and survivorship resources. In this study, researchers conducted a pilot using a web-based clinical pathways decision-support platform to provide customized survivorship resources for patients with cancer.
Gastroenterology
08/23/2024
Surveillance-detected cases of hepatocellular carcinoma were more likely to be unifocal and early-stage, and tumors were smaller than incident cases.
EMSWorld
08/23/2024
ImageTrend announces the purchase of FlowMSP, a company that provides a pre-incident planning process that works across any device and quickly distributes critical information via dispatch.
Rheumatology & Arthritis
08/23/2024
A recent study found no significant difference in the risk of cardiovascular events among rheumatoid arthritis patients treated with Janus kinase inhibitors or biologic disease-modifying drugs.
Foot and Ankle Surgery Institute
08/23/2024
Dr. James LaPolla, Jr. presents two cases using InnovaMatrix AC.
Journal of Clinical Pathways
08/23/2024
Delays in cancer treatment authorization often impede optimal patient care. In this retrospective assessment of payment rates, the Dana-Farber Cancer Institute explores payer approval decisions for on-pathway treatments.
Advances in Inflammatory Bowel Disease Network
08/23/2024
Complications among patients with ulcerative colitis undergoing colectomy were not associated with the drug class of preoperative therapies.
Journal of Clinical Pathways
08/23/2024
According to research published in the Journal of Clinical Oncology, clinical decision support (CDS) tools can foster an accelerated uptake of new therapies compared to non-users. In this study, researchers used a CDS tool called Flatiron AssistTM, embedded in the electronic health record (EHR), to facilitate the selection and documentation of National Comprehensive Cancer Network (NCCN) concordant treatment regimens, undergoing monthly updates aligned with NCCN Guidelines.
Reimbursement Library From A to Z
Subscribe and never miss an article!
Today's Wound Clinic Newsletter
